[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-108-2-medical-surgical-047":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":23},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":22},"nurse-108-2-內外科護理學-047","nurse-108-2-medical-surgical-047",108,2,47,"下列何者為自體免疫血清反應之實驗室檢查？",{"A":14,"B":15,"C":16,"D":17},"紅血球沉降率","抗核抗體（ANA）","滑膜液","C 反應蛋白質","B",null,[],"本題考點是自體免疫疾病的血清學檢查項目。依實驗室診斷,抗核抗體(ANA)是偵測血清中對抗細胞核成分的自體抗體,為系統性紅斑性狼瘡等自體免疫疾病的重要篩檢指標,屬自體免疫血清反應檢查,故選 B。A 紅血球沉降率(ESR)是非特異性發炎指標,無法特指自體免疫。C 滑膜液分析評估關節液性質(如感染或結晶),非血清自體抗體檢查。D C 反應蛋白(CRP)同為非特異性發炎急性期指標。考點在於辨識具「自體抗體」特異性的血清檢查,ANA 是代表。",1,[24,28,31,35,39,43],{"webId":25,"stem":26,"number":22,"year":27,"session":22},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":29,"stem":30,"number":10,"year":27,"session":22},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",{"webId":32,"stem":33,"number":34,"year":27,"session":22},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":27,"session":22},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":27,"session":22},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":27,"session":22},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840759154]